Mouse Anti-DUSP3 Recombinant Antibody (D1896) (V2LY-0425-LY1069)

Khbouz, B., Rowart, P., Poma, L., Dahlke, E., Bottner, M., Stokes, M., ... & Jouret, F. (2022). The genetic deletion of the Dual Specificity Phosphatase 3 (DUSP3) attenuates kidney damage and inflammation following ischaemia/reperfusion injury in mouse. Acta Physiologica, 234(2), e13735.

Jacques, S., Arjomand, A., Perée, H., Collins, P., Mayer, A., Lavergne, A., ... & Rahmouni, S. (2021). Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma. Scientific reports, 11(1), 1-15.

Kim, B. R., Ha, J., Kang, E., & Cho, S. (2020). Regulation of signal transducer and activator of transcription 3 activation by dual-specificity phosphatase 3. BMB reports, 53(6), 335.

Monteiro, L. F., Ferruzo, P. Y. M., Russo, L. C., Farias, J. O., & Forti, F. L. (2018). DUSP3/VHR: A druggable dual phosphatase for human diseases. Reviews of Physiology, Biochemistry and Pharmacology 176, 1-35.

Chen, Y. R., Chou, H. C., Yang, C. H., Chen, H. Y., Liu, Y. W., Lin, T. Y., ... & Tan, T. H. (2017). Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration. Oncogene, 36(47), 6509-6517.

Vandereyken, M. M., Singh, P., Wathieu, C. P., Jacques, S., Zurashvilli, T., Dejager, L., ... & Rahmouni, S. (2017). Dual-specificity phosphatase 3 deletion protects female, but not male, mice from endotoxemia-induced and polymicrobial-induced septic shock. The Journal of Immunology, 199(7), 2515-2527.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols